PYC Therapeutics Ltd (PYC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.203x

Based on the latest financial reports, PYC Therapeutics Ltd (PYC) has a cash flow conversion efficiency ratio of -0.203x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.54 Million ≈ $-24.44 Million USD) by net assets (AU$170.01 Million ≈ $120.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is PYC Therapeutics Ltd's balance sheet to measure how much of total assets are equity-financed.

PYC Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how PYC Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how aggressively does PYC Therapeutics Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

PYC Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PYC Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sinclair Broadcast Group Inc NASDAQ:SBGI	0.110x
Mills Estruturas e Serviços de Engenharia S.A SA:MILS3	0.103x
APAQ Technology Co Ltd TW:6449	0.048x
Once Upon a Farm, PBC NYSE:OFRM	0.054x
Lotte Reit Co Ltd KO:330590	N/A
Metalla Royalty & Streaming Ltd V:MTA	0.008x
Shenzhen Rapoo Technology SHE:002577	0.026x
ESGL Holdings Limited NASDAQ:OIO	-0.041x

Annual Cash Flow Conversion Efficiency for PYC Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of PYC Therapeutics Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see PYC stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$170.01 Million ≈ $120.29 Million	AU$-51.56 Million ≈ $-36.48 Million	-0.303x	+36.30%
2024-06-30	AU$81.05 Million ≈ $57.35 Million	AU$-38.59 Million ≈ $-27.30 Million	-0.476x	+44.55%
2023-06-30	AU$28.44 Million ≈ $20.12 Million	AU$-24.42 Million ≈ $-17.28 Million	-0.859x	-58.47%
2022-06-30	AU$40.20 Million ≈ $28.45 Million	AU$-21.78 Million ≈ $-15.41 Million	-0.542x	-147.78%
2021-06-30	AU$53.92 Million ≈ $38.15 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.219x	-14.86%
2020-06-30	AU$30.20 Million ≈ $21.37 Million	AU$-5.75 Million ≈ $-4.07 Million	-0.190x	+76.60%
2019-06-30	AU$6.30 Million ≈ $4.46 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.814x	+80.02%
2018-06-30	AU$1.65 Million ≈ $1.17 Million	AU$-6.71 Million ≈ $-4.75 Million	-4.072x	-1815.51%
2017-06-30	AU$8.86 Million ≈ $6.27 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.213x	+60.86%
2016-06-30	AU$5.83 Million ≈ $4.13 Million	AU$-3.17 Million ≈ $-2.24 Million	-0.543x	+78.94%
2015-06-30	AU$962.03K ≈ $680.70K	AU$-2.48 Million ≈ $-1.76 Million	-2.579x	-199.69%
2014-06-30	AU$3.72 Million ≈ $2.63 Million	AU$-3.20 Million ≈ $-2.26 Million	-0.861x	+55.58%
2013-06-30	AU$1.19 Million ≈ $845.45K	AU$-2.32 Million ≈ $-1.64 Million	-1.938x	-25.63%
2012-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.15 Million ≈ $-2.94 Million	-1.542x	-128.13%
2011-06-30	AU$4.35 Million ≈ $3.08 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.676x	-108.14%
2010-06-30	AU$-437.08K ≈ $-309.26K	AU$-3.63 Million ≈ $-2.57 Million	8.302x	+509.05%
2009-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-3.88 Million ≈ $-2.74 Million	-2.030x	-9.99%
2008-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.97 Million ≈ $-3.52 Million	-1.845x	-31.11%
2007-06-30	AU$2.20 Million ≈ $1.55 Million	AU$-3.09 Million ≈ $-2.19 Million	-1.407x	-5.96%
2006-06-30	AU$2.11 Million ≈ $1.50 Million	AU$-2.81 Million ≈ $-1.99 Million	-1.328x	-476.72%
2005-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.33 Million ≈ $-942.05K	-0.230x	-549.11%
2004-06-30	AU$546.00K ≈ $386.33K	AU$28.00K ≈ $19.81K	0.051x	--

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$682.50 Million

AU$964.57 Million AUD

Market Cap Rank

#10462 Global

#272 in Australia

Share Price

AU$1.62

Change (1 day)

+0.31%

52-Week Range

AU$0.85 - AU$1.74

All Time High

AU$2.05